The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction

被引:117
作者
Lupher, ML
Rao, N
Eck, MJ
Band, H
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Massachusetts Dept Publ Hlth, Boston, MA 02111 USA
来源
IMMUNOLOGY TODAY | 1999年 / 20卷 / 08期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0167-5699(99)01484-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Cbl protooncoprotein has recently emerged as a component of tyrosine kinase-mediated signal transduction in a variety of cell types. Here, we discuss evidence that supports a role for Cbl as a novel negative regulator of immune receptor signaling, and present models for its mode of function.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 62 条
  • [51] The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?
    Scharenberg, AM
    Kinet, JP
    [J]. CELL, 1996, 87 (06) : 961 - 964
  • [52] Clathrin-coated vesicle formation and protein sorting: An integrated process
    Schmid, SL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1997, 66 : 511 - 548
  • [53] Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase
    Suzuki, H
    Terauchi, Y
    Fujiwara, M
    Aizawa, S
    Yazaki, Y
    Kadowaki, T
    Koyasu, S
    [J]. SCIENCE, 1999, 283 (5400) : 390 - 392
  • [54] Physical and functional association of the cbl protooncogene product with an Src-family protein tyrosine kinase, p53/56(lyn), in the B cell antigen receptor-mediated signaling
    Tezuka, T
    Umemori, H
    Fusaki, N
    Yagi, T
    Takata, M
    Kurosaki, T
    Yamamoto, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 675 - 680
  • [55] c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway
    Ueno, H
    Sasaki, K
    Honda, H
    Nakamoto, T
    Yamagata, T
    Miyagawa, K
    Mitani, K
    Yazaki, Y
    Hirai, H
    [J]. BLOOD, 1998, 91 (01) : 46 - 53
  • [56] Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol S-kinase association
    van Leeuwen, JEM
    Paik, PK
    Samelson, LE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) : 5153 - 5162
  • [57] c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages
    Wang, Y
    Yeung, YG
    Langdon, WY
    Stanley, ER
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) : 17 - 20
  • [58] Complex complexes: Signaling at the TCR
    Wange, RL
    Samelson, LE
    [J]. IMMUNITY, 1996, 5 (03) : 197 - 205
  • [59] SIMILARITY OF SLI-1, A REGULATOR OF VULVAR DEVELOPMENT IN C-ELEGANS, TO THE MAMMALIAN PROTOONCOGENE C-CBL
    YOON, CH
    LEE, JH
    JONGEWARD, GD
    STERNBERG, PW
    [J]. SCIENCE, 1995, 269 (5227) : 1102 - 1105
  • [60] LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation
    Zhang, WG
    Sloan-Lancaster, J
    Kitchen, J
    Trible, RP
    Samelson, LE
    [J]. CELL, 1998, 92 (01) : 83 - 92